Identification of Cell-Free Circulating MicroRNAs for the Detection of Early Breast Cancer and Molecular Subtyping
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of Cell-Free Circulating MicroRNAs for the Detection of Early Breast Cancer and Molecular Subtyping
Authors
Keywords
-
Journal
Journal of Oncology
Volume 2019, Issue -, Pages 1-11
Publisher
Hindawi Limited
Online
2019-08-09
DOI
10.1155/2019/8393769
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2
- (2018) Hua Chen et al. Molecular Cancer
- A serum microRNA signature predicts trastuzumab benefit in HER2-positive metastatic breast cancer patients
- (2018) Huiping Li et al. Nature Communications
- Association of miR-548c-5p, miR-7-5p, miR-210-3p, miR-128-3p with recurrence in systemically untreated breast cancer
- (2018) Ines Block et al. Oncotarget
- Expression of tumor suppressors miR-195 and let-7a as potential biomarkers of invasive breast cancer
- (2018) MM Marques et al. Clinics
- Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
- (2017) M.J. Duffy et al. EUROPEAN JOURNAL OF CANCER
- Integrating liquid biopsies into the management of cancer
- (2017) Giulia Siravegna et al. Nature Reviews Clinical Oncology
- Downregulation of miR-221-3p and upregulation of its target gene PARP1 are prognostic biomarkers for triple negative breast cancer patients and associated with poor prognosis
- (2017) Ling Deng et al. Oncotarget
- Identification of a circulating microRNA signature to distinguish recurrence in breast cancer patients
- (2016) Dezheng Huo et al. Oncotarget
- Circulating cell-free miRNAs as biomarker for triple-negative breast cancer
- (2015) V Y Shin et al. BRITISH JOURNAL OF CANCER
- Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer
- (2015) Yingbo Shao et al. PLoS One
- Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients
- (2015) Isabel Stückrath et al. Oncotarget
- MicroRNAs and Cancer; an Overview
- (2014) Lutfi Tutar et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- How Many Etiological Subtypes of Breast Cancer: Two, Three, Four, Or More?
- (2014) W. F. Anderson et al. JNCI-Journal of the National Cancer Institute
- MicroRNAs in cancer: biomarkers, functions and therapy
- (2014) Josie Hayes et al. TRENDS IN MOLECULAR MEDICINE
- Identification of Circulating MicroRNA Signatures for Breast Cancer Detection
- (2013) M. Chan et al. CLINICAL CANCER RESEARCH
- Multiple Biomarker Panels for Early Detection of Breast Cancer in Peripheral Blood
- (2013) Fan Zhang et al. Biomed Research International
- Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer
- (2010) Helen M. Heneghan et al. ANNALS OF SURGERY
- Serum microRNAs as powerful cancer biomarkers
- (2010) Jürgen Wittmann et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor
- (2010) Fengjun Wang et al. GYNECOLOGIC ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started